Last reviewed · How we verify

NCT05485415: CIEL

Intervention Study in Elderly With Sleep Problems

Active, enrolled NA Last updated 28 March 2025
What this trial tests

NA trial testing Multimodal intervention in Sleep Disturbance in 66 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 July 2022
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorMirjam Münch
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment66
Start date15 July 2022
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Mirjam Münch

Who can join

65 and older, any sex, with Sleep Disturbance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to improve subjective sleep quality using a multimodal intervention with an intervention and a control group. The multimodal intervention aims to improve circadian Zeitgeber strength. This will be achieved by optimizing daily light exposure, sleep, physical activity, and mealtimes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Multimodal intervention

Trials testing the same drug.

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05485415.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing